Decrease in Bcl-2 Protein Level during the Development of Lewis Carcinosarcome


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

We studied the development of Lewis carcinoma and possible antitumor effect of preliminary administered antioxidant anphen. The tumor was intramuscularly transplanted to C57Bl×DBA mice (7×106 cells per mouse). According to immunoblotting results, the content of anti-apoptotic Bcl-2 protein steadily decreased starting from post-transplantation day 11. In few days, its content decreased by 15-20% and soon the animals died. After administration of anphen, the content of Bcl-2 decreased more rapidly than in the control. Atomic force microscopy revealed a decrease in the mean volume of erythrocytes and then increase in this parameter at the terminal stage of tumor growth. These findings suggest that anphen does not affect the tumor growth rate and mouse lifespan, but enhances apoptosis of blood cells of animals with Lewis carcinoma at the terminal stages of tumor growth.

Sobre autores

E. Mil’

N. M. Emanuel Institute of Biochemical Physics, Russian Academy of Sciences

Autor responsável pela correspondência
Email: elenamil2004@mail.ru
Rússia, Moscow

V. Erokhin

N. M. Emanuel Institute of Biochemical Physics, Russian Academy of Sciences

Email: elenamil2004@mail.ru
Rússia, Moscow

V. Binyukov

N. M. Emanuel Institute of Biochemical Physics, Russian Academy of Sciences

Email: elenamil2004@mail.ru
Rússia, Moscow

V Semenov

N. M. Emanuel Institute of Biochemical Physics, Russian Academy of Sciences

Email: elenamil2004@mail.ru
Rússia, Moscow

A. Albantova

N. M. Emanuel Institute of Biochemical Physics, Russian Academy of Sciences

Email: elenamil2004@mail.ru
Rússia, Moscow

S. Blokhina

Institute of Problems of Chemical Physics, Russian Academy of Sciences

Email: elenamil2004@mail.ru
Rússia, Moscow

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2018